Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 2 de may. de 2024 · Max Mathews, 'father of computer music,' dies at 84 . May 2, 2011, Cynthia Haven, Stanford Report In 1957, Max Mathews invented a program that allowed a mainframe computer to play a 17-second musical composition. The technical breakthrough is still reverberating. Read More

  2. 15 de abr. de 2024 · It was originally called The Patcher until the idea was licensed by Opcode in 1990 and renamed Max, after Max Mathews, a pioneer in digital audio research and technology who spent much of his career at Bell Labs where he developed the first widely used program for sound generation, MUSIC.

  3. 19 de abr. de 2024 · On April 21st, our friend and colleague Max Mathews passed away. He had been recently hospitalized in San Francisco for pneumonia. Max's presence is so fresh for all at CCRMA and beyond. He was regularly spending much of each week engaged with music, new projects and students here and elsewhere.

  4. Hace 2 días · Max Mathews Portrait; Research Groups; Software; People. Faculty and Staff; Students; Alumni; All Users; User Guides. New Documentation; Booking Events; Common Areas; Rooms; System; Resources. Planet CCRMA; MARL; Blogs; Opportunities. CFPs; About. The Knoll. Renovation; Directions; Contact

  5. 16 de abr. de 2024 · The Scalatron was an unusual microtonal electronic instrument developed in the early 1970s by Motorola as a new venture into the instrument market. Promoted as the ‘first instant-performance instrument that plays in the cracks’ the Scalatron was aimed squarely at a more experimental, microtonal market – if such a market existed.

  6. Hace 3 días · Max Mathews·. Live Reporter. Reminder: Subscribe to The Athletic. In case you missed our earlier call to action, here you are: The Athletic is an industry-leading home for world-class sports...

  7. 1 de may. de 2024 · The Mathews Griner dataset was generated in a high-throughput drug combination screening study conducted to explore potential drug synergies and antagonisms in a panel of 459 compounds combined with the Tyrosine Kinase inhibitor ibrutinib in cancer cell lines from the activated B-cell like subtype of diffuse large B-cell lymphoma ...